Announcement
19 Dec 2025
In December 2025, the United States government announced an agreement with Sanofi to implement most-favoured-nation drug pricing for American patients.
Source
Sign in to access
Number of interventions
4
0 certainly harmful
4 likely harmful
0 liberalising
List of interventions
Implementation date
No implementation date
Revocation date:
No revocation date
Updated: 05 Apr 2026
Local operations incentive
Recent update from 05 Apr 2026:
On 19 December 2025, the U.S. Administration announced an agreement with Sanofi. Under the agreement, Sanofi will be free from Section 232 tariffs on its imported products for three years, in excha...
Sign in to see more
Updated: 05 Apr 2026
FDI: Financial incentive
Recent update from 05 Apr 2026:
On 19 December 2025, the U.S. Administration announced an agreement with Sanofi. Under the agreement, Sanofi committed to make investments in manufacturing in the United States. In return, Sanofi w...
Sign in to see more
Updated: 05 Apr 2026
Tax or social insurance relief
Recent update from 05 Apr 2026:
On 19 December 2025, the U.S. Administration announced reaching an agreement with Sanofi. Under the agreement, Sanofi will be free from Section 232 tariffs on its imported products for three years,...
Sign in to see more
Updated: 05 Apr 2026
Import tariff
Recent update from 05 Apr 2026:
On 19 December 2025, the United States announced an agreement with Sanofi providing the company with a three-year period free from Section 232 tariffs. In exchange, Sanofi agreed to implement most-...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.